Elagolix freeze-dried tablets and preparation method thereof
The invention discloses elagolix freeze-dried tablets. The elagolix freeze-dried tablets comprise an active ingredient elagolix, an excipient, an adhesive, a pH regulator, a taste masking agent, a flavoring agent and a solvent, and comprises the following components in parts by weight: 200 parts of...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
04.01.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention discloses elagolix freeze-dried tablets. The elagolix freeze-dried tablets comprise an active ingredient elagolix, an excipient, an adhesive, a pH regulator, a taste masking agent, a flavoring agent and a solvent, and comprises the following components in parts by weight: 200 parts of active component elagolix, 30-50 parts of excipient, 20-50 parts of adhesive, 5-20 parts of pH regulator, 1-5 parts of taste masking agent, 10-40 parts of flavoring agent and 800-900 parts of solvent. The invention further discloses a preparation method of the elagolix freeze-dried tablets. The elagolix freeze-dried tablets and the preparation method thereof have the following advantages: no dust is generated in the production process, and the environmental pollution is less; the prepared products are smaller in tablet weight and adopt fewer auxiliary materials; the freeze-dried tablets are low in water content and stable in quality, and impurities are hardly increased in the storage process; in the clinical using |
---|---|
Bibliography: | Application Number: CN202111361201 |